Filing Details
- Accession Number:
- 0001209191-14-017635
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-05 20:07:07
- Reporting Period:
- 2014-03-03
- Filing Date:
- 2014-03-05
- Accepted Time:
- 2014-03-05 20:07:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1206199 | G Daniel Welch | 3280 Bayshore Boulevard Brisbane CA 94005 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-03-03 | 15,655 | $31.52 | 121,779 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares sold in this transaction were acquired purusant to a vesting of performance stock award granted in June of 2012. The number of shares sold were only that which was necessary to cover the taxes owed upon the release of shares upon the vesting of such performance stock award.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $31.24 to $31.93 per share. Full information on the numbers of shares sold at each sale price is available upon request.